Process View
Any process that increases the rate, frequency or extent of plasminogen activation. Plasminogen activation is the process in which plasminogen is processed to plasmin.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of plasminogen activation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 1.000 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.895 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.721 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.447 | ||
| GAST | gastrin | 0.413 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.285 | ||
| KNG1 | kininogen 1 | 0.259 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.158 | ||
| PIGR | polymeric immunoglobulin receptor | 0.110 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.110 | ||
| ORM1 | orosomucoid 1 | 0.083 | ||
| ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 0.081 | ||
| WFDC2 | WAP four-disulfide core domain 2 | 0.075 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.070 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.069 | ||
| FGB | fibrinogen beta chain | 0.069 | ||
| FUT6 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 0.068 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.062 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.055 | ||
| STC1 | stanniocalcin 1 | 0.052 | ||
| IL8 | interleukin 8 | 0.050 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.050 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.050 | ||
| SAA4 | serum amyloid A4, constitutive | 0.048 | ||
| ECM1 | extracellular matrix protein 1 | 0.047 | ||
| C4BPB | complement component 4 binding protein, beta | 0.045 | ||
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.044 | ||
| FOSL1 | FOS-like antigen 1 | 0.043 | ||
| LCN2 | lipocalin 2 | 0.043 | ||
| CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.042 | ||
| PRSS8 | protease, serine, 8 | 0.041 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.040 | ||
| LAMC3 | laminin, gamma 3 | 0.039 | ||
| MUC4 | mucin 4, cell surface associated | 0.039 | ||
| TMPRSS11D | transmembrane protease, serine 11D | 0.038 | ||
| C8A | complement component 8, alpha polypeptide | 0.036 | ||
| TMPRSS2 | transmembrane protease, serine 2 | 0.036 | Human | |
| RAB17 | RAB17, member RAS oncogene family | 0.036 | ||
| TFR2 | transferrin receptor 2 | 0.035 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.035 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.034 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.034 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.033 | ||
| FXYD3 | FXYD domain containing ion transport regulator 3 | 0.033 | ||
| AMT | aminomethyltransferase | 0.033 | ||
| CRP | C-reactive protein, pentraxin-related | 0.032 | ||
| HPX | hemopexin | 0.031 | ||
| TFF1 | trefoil factor 1 | 0.031 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.031 | ||
| S100A2 | S100 calcium binding protein A2 | 0.030 | ||
| TFF3 | trefoil factor 3 (intestinal) | 0.030 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.029 | ||
| C8G | complement component 8, gamma polypeptide | 0.029 | ||
| F2 | coagulation factor II (thrombin) | 0.029 | ||
| AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.029 | ||
| XDH | xanthine dehydrogenase | 0.028 | ||
| GCGR | glucagon receptor | 0.027 | ||
| SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.027 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.027 | ||
| SPHK1 | sphingosine kinase 1 | 0.026 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.026 | ||
| CPA3 | carboxypeptidase A3 (mast cell) | 0.025 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.025 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.025 | ||
| CEACAM5 | carcinoembryonic antigen-related cell adhesion molecule 5 | 0.025 | ||
| PDZK1IP1 | PDZK1 interacting protein 1 | 0.025 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.024 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.024 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.024 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.023 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.023 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.023 | ||
| THBD | thrombomodulin | 0.023 | ||
| LAMB3 | laminin, beta 3 | 0.023 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.022 | ||
| C9 | complement component 9 | 0.022 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.022 | ||
| CP | ceruloplasmin (ferroxidase) | 0.022 | ||
| CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.021 | ||
| CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.021 | ||
| PRSS22 | protease, serine, 22 | 0.021 | ||
| TTR | transthyretin | 0.021 | ||
| TMPRSS4 | transmembrane protease, serine 4 | 0.020 | Human | |
| VIL1 | villin 1 | 0.020 | ||
| ALB | albumin | 0.020 | ||
| G0S2 | G0/G1switch 2 | 0.020 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.020 | ||
| PON3 | paraoxonase 3 | 0.020 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.020 | ||
| FTCD | formiminotransferase cyclodeaminase | 0.019 | ||
| APCS | amyloid P component, serum | 0.019 | ||
| LECT2 | leukocyte cell-derived chemotaxin 2 | 0.019 | ||
| TNC | tenascin C | 0.019 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.019 | ||
| C1orf116 | chromosome 1 open reading frame 116 | 0.019 | ||
| DMBT1 | deleted in malignant brain tumors 1 | 0.019 | ||
| TAT | tyrosine aminotransferase | 0.019 | ||
| AFM | afamin | 0.019 | ||
| GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0.019 | ||
| SLPI | secretory leukocyte peptidase inhibitor | 0.019 | ||
| RAB25 | RAB25, member RAS oncogene family | 0.019 | ||
| B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | 0.019 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.018 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.018 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.018 | ||
| TM4SF5 | transmembrane 4 L six family member 5 | 0.018 | ||
| HABP2 | hyaluronan binding protein 2 | 0.018 | Human | |
| PDPN | podoplanin | 0.018 | ||
| SGK2 | serum/glucocorticoid regulated kinase 2 | 0.018 | ||
| MFAP4 | microfibrillar-associated protein 4 | 0.018 | ||
| MUC5B | mucin 5B, oligomeric mucus/gel-forming | 0.018 | ||
| TMC5 | transmembrane channel-like 5 | 0.018 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.018 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.018 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.018 | ||
| F11 | coagulation factor XI | 0.018 | ||
| FUT3 | fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | 0.018 | ||
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.018 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.017 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.017 | ||
| TSPAN1 | tetraspanin 1 | 0.017 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.017 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.017 | ||
| SLC34A2 | solute carrier family 34 (sodium phosphate), member 2 | 0.017 | ||
| SPP1 | secreted phosphoprotein 1 | 0.017 | ||
| NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0.017 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.017 | ||
| PGR | progesterone receptor | 0.017 | ||
| APOF | apolipoprotein F | 0.017 | ||
| CDHR2 | cadherin-related family member 2 | 0.017 | ||
| GGTLC1 | gamma-glutamyltransferase light chain 1 | 0.017 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.017 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.016 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.016 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.016 | ||
| ARG1 | arginase, liver | 0.016 | ||
| PRR15L | proline rich 15-like | 0.016 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.016 | ||
| AGR2 | anterior gradient homolog 2 (Xenopus laevis) | 0.016 | ||
| UGT1A3 | UDP glucuronosyltransferase 1 family, polypeptide A3 | 0.016 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.016 | ||
| DUOX2 | dual oxidase 2 | 0.016 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.016 | ||
| EMP1 | epithelial membrane protein 1 | 0.016 | ||
| GPR110 | G protein-coupled receptor 110 | 0.016 | ||
| HPN | hepsin | 0.016 | ||
| TCN1 | transcobalamin I (vitamin B12 binding protein, R binder family) | 0.016 | ||
| F10 | coagulation factor X | 0.015 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.015 | ||
| HOMER3 | homer homolog 3 (Drosophila) | 0.015 | ||
| ST14 | suppression of tumorigenicity 14 (colon carcinoma) | 0.015 | ||
| GCNT3 | glucosaminyl (N-acetyl) transferase 3, mucin type | 0.015 | ||
| APOA1 | apolipoprotein A-I | 0.015 | ||
| GRIP1 | glutamate receptor interacting protein 1 | 0.015 | ||
| SLC5A1 | solute carrier family 5 (sodium/glucose cotransporter), member 1 | 0.015 | ||
| APOD | apolipoprotein D | 0.015 | ||
| MAPK15 | mitogen-activated protein kinase 15 | 0.015 | ||
| PLXNB1 | plexin B1 | 0.015 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.015 | ||
| C9orf7 | chromosome 9 open reading frame 7 | 0.015 | ||
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.015 | ||
| PDLIM4 | PDZ and LIM domain 4 | 0.015 | ||
| DPT | dermatopontin | 0.015 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.015 | ||
| SPRR3 | small proline-rich protein 3 | 0.015 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.015 | ||
| ECHDC2 | enoyl CoA hydratase domain containing 2 | 0.014 | ||
| IGFBP1 | insulin-like growth factor binding protein 1 | 0.014 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.014 | ||
| BSPRY | B-box and SPRY domain containing | 0.014 | ||
| SULT1C2 | sulfotransferase family, cytosolic, 1C, member 2 | 0.014 | ||
| ITGB6 | integrin, beta 6 | 0.014 | ||
| PRMT2 | protein arginine methyltransferase 2 | 0.014 | ||
| GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) | 0.014 | ||
| LGALS4 | lectin, galactoside-binding, soluble, 4 | 0.014 | ||
| ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | 0.014 | ||
| HBQ1 | hemoglobin, theta 1 | 0.014 | ||
| OVOL2 | ovo-like 2 (Drosophila) | 0.014 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.014 | ||
| TM4SF4 | transmembrane 4 L six family member 4 | 0.014 | ||
| DIO1 | deiodinase, iodothyronine, type I | 0.014 | ||
| PDGFC | platelet derived growth factor C | 0.014 | ||
| PROM1 | prominin 1 | 0.014 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.014 | ||
| GLP1R | glucagon-like peptide 1 receptor | 0.013 | ||
| LIPC | lipase, hepatic | 0.013 | ||
| RHBDL1 | rhomboid, veinlet-like 1 (Drosophila) | 0.013 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.013 | ||
| S100A14 | S100 calcium binding protein A14 | 0.013 | ||
| LPA | lipoprotein, Lp(a) | 0.013 | Human | |
| APOM | apolipoprotein M | 0.013 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.013 | ||
| UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 | 0.013 | ||
| CDX1 | caudal type homeobox 1 | 0.013 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.013 | ||
| GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.013 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.013 | ||
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.013 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.013 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.013 | ||
| ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | 0.013 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.013 | ||
| PLG | plasminogen | 0.013 | Human | |
| GPX2 | glutathione peroxidase 2 (gastrointestinal) | 0.012 | ||
| RORC | RAR-related orphan receptor C | 0.012 | ||
| TUBB6 | tubulin, beta 6 | 0.012 | ||
| SLC6A14 | solute carrier family 6 (amino acid transporter), member 14 | 0.012 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.012 | ||
| EPS8L1 | EPS8-like 1 | 0.012 | ||
| C8B | complement component 8, beta polypeptide | 0.012 | ||
| TACSTD2 | tumor-associated calcium signal transducer 2 | 0.012 | ||
| OSMR | oncostatin M receptor | 0.012 | ||
| ACE2 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 | 0.012 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.012 | ||
| GNMT | glycine N-methyltransferase | 0.012 | ||
| NRP2 | neuropilin 2 | 0.012 | ||
| MUC1 | mucin 1, cell surface associated | 0.012 | ||
| SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.012 | ||
| ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 0.012 | ||
| CCND1 | cyclin D1 | 0.012 | ||
| DDC | dopa decarboxylase (aromatic L-amino acid decarboxylase) | 0.012 | ||
| C19orf46 | chromosome 19 open reading frame 46 | 0.012 | ||
| PNRC2 | proline-rich nuclear receptor coactivator 2 | 0.012 | ||
| CCNO | cyclin O | 0.012 | ||
| FUT2 | fucosyltransferase 2 (secretor status included) | 0.012 | ||
| GUCY2D | guanylate cyclase 2D, membrane (retina-specific) | 0.012 | ||
| DPYS | dihydropyrimidinase | 0.012 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.012 | ||
| SPINK5 | serine peptidase inhibitor, Kazal type 5 | 0.012 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.012 | ||
| CLDN3 | claudin 3 | 0.012 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.012 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.012 | ||
| CTSE | cathepsin E | 0.011 | ||
| VTCN1 | V-set domain containing T cell activation inhibitor 1 | 0.011 | ||
| TMEM158 | transmembrane protein 158 (gene/pseudogene) | 0.011 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.011 | ||
| INHBA | inhibin, beta A | 0.011 | ||
| C10orf46 | chromosome 10 open reading frame 46 | 0.011 | ||
| SEC14L2 | SEC14-like 2 (S. cerevisiae) | 0.011 | ||
| SCGB2A1 | secretoglobin, family 2A, member 1 | 0.011 | ||
| MICAL2 | microtubule associated monoxygenase, calponin and LIM domain containing 2 | 0.011 | ||
| SLC28A3 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 | 0.011 | ||
| FCGBP | Fc fragment of IgG binding protein | 0.011 | ||
| RHCG | Rh family, C glycoprotein | 0.011 | ||
| HRH1 | histamine receptor H1 | 0.011 | ||
| SCGB3A1 | secretoglobin, family 3A, member 1 | 0.011 | ||
| FOXA1 | forkhead box A1 | 0.011 | ||
| SLC6A13 | solute carrier family 6 (neurotransmitter transporter, GABA), member 13 | 0.011 | ||
| LBP | lipopolysaccharide binding protein | 0.011 | ||
| PLXNB3 | plexin B3 | 0.011 | ||
| RNF186 | ring finger protein 186 | 0.011 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.011 | ||
| EFNA1 | ephrin-A1 | 0.011 | ||
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.011 | ||
| CFI | complement factor I | 0.011 | ||
| TMEM30B | transmembrane protein 30B | 0.011 | ||
| VTN | vitronectin | 0.011 | ||
| PLA2G10 | phospholipase A2, group X | 0.011 | ||
| F12 | coagulation factor XII (Hageman factor) | 0.011 | ||
| RAB26 | RAB26, member RAS oncogene family | 0.011 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.011 | ||
| ZCWPW1 | zinc finger, CW type with PWWP domain 1 | 0.011 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.011 | ||
| CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 0.011 | ||
| VIPR1 | vasoactive intestinal peptide receptor 1 | 0.011 | ||
| CDH16 | cadherin 16, KSP-cadherin | 0.011 | ||
| CFB | complement factor B | 0.011 | ||
| C6 | complement component 6 | 0.011 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.011 | ||
| MALL | mal, T-cell differentiation protein-like | 0.010 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.010 | ||
| CYP17A1 | cytochrome P450, family 17, subfamily A, polypeptide 1 | 0.010 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.010 | ||
| SDC1 | syndecan 1 | 0.010 | ||
| GJB5 | gap junction protein, beta 5, 31.1kDa | 0.010 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.010 | ||
| GLS2 | glutaminase 2 (liver, mitochondrial) | 0.010 | ||
| EHF | ets homologous factor | 0.010 | ||
| CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 | 0.010 | ||
| ANGPT2 | angiopoietin 2 | 0.010 | ||
| CA9 | carbonic anhydrase IX | 0.010 | ||
| FOLR2 | folate receptor 2 (fetal) | 0.010 | ||
| GOLT1A | golgi transport 1A | 0.010 | ||
| PROCR | protein C receptor, endothelial | 0.010 | ||
| SLC9A2 | solute carrier family 9 (sodium/hydrogen exchanger), member 2 | 0.010 | ||
| F9 | coagulation factor IX | 0.010 | ||
| STAB2 | stabilin 2 | 0.010 | ||
| CLDN4 | claudin 4 | 0.010 |